Xlife Sciences AG (XLS) — Capital Reinvestment Ratio
Xlife Sciences AG (XLS) has a Capital Reinvestment Ratio of 0.24x as of December 2023, meaning it reinvests 0% of its operating cash flow (CHF171.78K) in capital expenditures (CHF41.08K). See Xlife Sciences AG (XLS) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xlife Sciences AG Capital Reinvestment Ratio (2023–2023)
This chart tracks Xlife Sciences AG's Capital Reinvestment Ratio across 1 annual periods. Check XLS total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Xlife Sciences AG (2023–2023)
Year-by-year Capital Reinvestment Ratio for Xlife Sciences AG from 2023 to 2023. For live market cap and broader valuation context, see XLS market cap.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.24x | CHF171.78K | CHF41.08K | — |